InsidersTradesSigma
Follow the 텔콘RF제약 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 텔콘RF제약 has logged 33 reports. Market capitalisation: €15.3bn. The latest transaction was reported on 16 July 2026 (Other). Among the most active insiders: 뉴온. Every trade is accessible without an account.
33
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
13 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,476 of 29,063 companies
9.9
score / 100
Value8
Quality12
FCF yld-22%
Earn yld-43%
EV/EBITDA·
ROE-17%
Gross mgn8.6%
Net mgn-10%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
Declarations33 total
2,329,916 sharesKRXDART:20260716000738
2,989,916 sharesShareKRXDART:20260716000723
25 of 33 declarations
关于 텔콘RF제약
텔콘RF제약 是一家在 XKRX 市场上市的医疗保健和制药公司。该公司专注于创新药物产品的开发。